Literature DB >> 8865202

Localization and developmental changes in the neuron-specific cyclin-dependent kinase 5 activator (p35nck5a) in the rat brain.

K Tomizawa1, H Matsui, M Matsushita, J Lew, M Tokuda, T Itano, R Konishi, J H Wang, O Hatase.   

Abstract

Mammalian brains contain a cde2-like protein kinase which is a heterodimer of cyclin-dependent kinase 5 (Cdk5) and a brain-specific regulatory subunit with a molecular weight of 35,000. In this study, we examined the temporal and spatial expression patterns of p35nck5a in the developing rat brain. Northern blot analysis showed that p35nck5a messenger RNA expression was low in the brain of 12-day postcoitum rats, and increased to a much higher level from 18 days postcoitum to two weeks after birth, and then declined at three weeks after birth. These developmental changes in p35nck5a expression correlated with the changes in Cdk5-associated kinase activity during brain development. These data suggest that p35nck5a is the specific activator for Cdk5 in the brain. Immunohistochemical and in situ hybridization studies demonstrated the presence of p35nck5a protein in postmitotic neurons but not in glial cells at all stages of brain development, indicating that p35nck5a is a neuron-specific protein. In the adult brain, the protein was rich in cell bodies and dendrites, and only very low amounts were detected in axons. In fetal and neonatal brains, however, axonal pathways such as the corpus callosum and external capsule were also stained with anti-p35nck5a antibody. Our findings suggest that p35nck5a is neuron specific, and a specific activator for Cdk5, and the subcellular localization of the two is strictly regulated depending on brain development. Neuronal Cdc2-like kinase may play key roles in neuronal maturation, synaptic formation, and neuronal plasticity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865202     DOI: 10.1016/0306-4522(96)00136-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.

Authors:  Kazuhito Tomizawa; Jun Ohta; Masayuki Matsushita; Akiyoshi Moriwaki; Sheng-Tian Li; Kohji Takei; Hideki Matsui
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

Authors:  G Paglini; G Pigino; P Kunda; G Morfini; R Maccioni; S Quiroga; A Ferreira; A Cáceres
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

3.  Neuronal cyclin-dependent kinase 5 activity is critical for survival.

Authors:  T Tanaka; T Ohshima; P Rajan; N D Amin; A Cho; T Sreenath; H C Pant; R O Brady; A B Kulkarni
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

4.  Inhibition of Cdk5 increases osteoblast differentiation and bone mass and improves fracture healing.

Authors:  Mubashir Ahmad; Benjamin Thilo Krüger; Torsten Kroll; Sabine Vettorazzi; Ann-Kristin Dorn; Florian Mengele; Sooyeon Lee; Sayantan Nandi; Dilay Yilmaz; Miriam Stolz; Naveen Kumar Tangudu; David Carro Vázquez; Johanna Pachmayr; Ion Cristian Cirstea; Maja Vujic Spasic; Aspasia Ploubidou; Anita Ignatius; Jan Tuckermann
Journal:  Bone Res       Date:  2022-04-06       Impact factor: 13.567

5.  Peripheral and orofacial pain sensation is unaffected by the loss of p39.

Authors:  Michaela Prochazkova; Bradford Hall; Minghan Hu; Tracy Okine; Jennifer Reukauf; B K Binukumar; Niranjana D Amin; Eva Roque; Harish C Pant; Ashok Kulkarni
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.